Pictet Asset Management Holding SA Acquires Shares of 21,440 Genpact Limited (NYSE:G)

Pictet Asset Management Holding SA bought a new stake in shares of Genpact Limited (NYSE:GFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 21,440 shares of the business services provider’s stock, valued at approximately $921,000.

Several other large investors have also recently modified their holdings of G. SRH Advisors LLC purchased a new position in Genpact during the fourth quarter worth $26,000. Manchester Capital Management LLC bought a new stake in shares of Genpact in the 4th quarter worth about $38,000. Smartleaf Asset Management LLC boosted its stake in shares of Genpact by 416.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after purchasing an additional 783 shares during the period. UMB Bank n.a. grew its holdings in Genpact by 55.7% during the 4th quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock valued at $52,000 after purchasing an additional 433 shares during the last quarter. Finally, J.Safra Asset Management Corp raised its position in Genpact by 38.8% in the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock worth $69,000 after purchasing an additional 453 shares during the period. Institutional investors own 96.03% of the company’s stock.

Insider Activity at Genpact

In other news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Piyush Mehta sold 12,000 shares of the firm’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. 2.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and upped their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Mizuho increased their target price on Genpact from $45.00 to $55.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Needham & Company LLC boosted their target price on shares of Genpact from $55.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Finally, Jefferies Financial Group raised shares of Genpact from a “hold” rating to a “buy” rating and raised their price target for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Six investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Genpact has a consensus rating of “Hold” and a consensus price target of $48.44.

Get Our Latest Research Report on Genpact

Genpact Stock Down 3.7 %

Shares of Genpact stock opened at $47.08 on Monday. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. The stock has a market cap of $8.27 billion, a price-to-earnings ratio of 16.58, a PEG ratio of 1.84 and a beta of 1.06. The firm’s 50-day moving average is $51.20 and its two-hundred day moving average is $45.49. Genpact Limited has a 1 year low of $30.23 and a 1 year high of $56.76.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. As a group, research analysts expect that Genpact Limited will post 3.21 earnings per share for the current fiscal year.

Genpact Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th were paid a dividend of $0.17 per share. This is a boost from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date was Tuesday, March 11th. Genpact’s dividend payout ratio is 23.94%.

About Genpact

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.